Evidence map›Paper›PMID 36136648›Full record

ArticleTropical medicine and infectious disease2022

Delays in TB Diagnosis and Treatment Initiation in Burkina Faso during the COVID-19 Pandemic.

Adama Diallo, Adjima Combary, Vanessa Veronese, Désiré Lucien Dahourou, Salifou Ouédraogo, Isidore Tiandiogo Traoré, Corinne Simone Merle

Open access · goldAbstract read
In one paragraph

Article in Tropical medicine and infectious disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Adama DialloNational Tuberculosis Control Program, Ouagadougou P.O. Box 6632, Burkina Faso.ORCID 0000-0002-9421-0054
Adjima CombaryNational Tuberculosis Control Program, Ouagadougou P.O. Box 6632, Burkina Faso.
Vanessa VeroneseSpecial Programme for Research & Training in Tropical Diseases (TDR), World Health Organization, 1211 Geneva, Switzerland.
Désiré Lucien DahourouDépartement Biomédical/Santé Publique, Institut de Recherche en Sciences de la Santé, Ouagadougou P.O. Box 7192, Burkina Faso.
Salifou OuédraogoNational Tuberculosis Control Program, Ouagadougou P.O. Box 6632, Burkina Faso.
Isidore Tiandiogo TraoréInstitut Supérieur des Sciences de la Santé, Université Nazi Boni, Bobo-Dioulasso P.O. Box 1091, Burkina Faso.ORCID 0000-0003-1135-5715
Corinne Simone MerleSpecial Programme for Research & Training in Tropical Diseases (TDR), World Health Organization, 1211 Geneva, Switzerland.ORCID 0000-0003-4229-365X
World Health Organization · CHInstitut de Recherche en Sciences de la Santé · BFNazi Boni University · BF

Funding

World Health Organization 001
6 · The paper itself

Abstract

The COVID-19 pandemic has significantly disrupted TB services, particularly in low resource settings. In Burkina Faso, a cross-sectional ‘before and after’ study was conducted to assess the impact of COVID-19 on access to TB services. Data was collected in two phases (Phase 1: December 2017−March 2018, and 2: October−December 2020) to estimate and compare various patient and system delays among TB patients before and during COVID-19 and explore changes in treatment seeking behaviors and practices. 331 TB patients were recruited across the two phases. A significant increase in median time between first symptom and contact with TB service (45 days vs. 26 days; p < 0.01) and decrease in median time between first contact and diagnosis, and treatment initiation, respectively, during COVID-19 compared to before. Fewer patients reported using public health centers and more patients reporting using private facilities as the point of first contact following TB symptom onset during the COVID-19 period compared to before. These findings suggest that COVID-19 has created barriers to TB service access and health seeking among symptomatic individuals, yet also led to some efficiencies in TB diagnostic and treatment services. Our findings can be help target efforts along specific points of the TB patient pathway to minimize the overall disruption of COVID-19 and future public health emergencies on TB control in Burkina Faso.

Indexed as

Burkina FasoCOVID-19treatment delaystuberculosis

Identifiers

PMID36136648
PMCPMC9500868
OpenAlexW4296019807

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.